The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Emergence of Multidrug-Resistant, Extensively Drug-Resistant and Untreatable Gonorrhea
Open accessAbstract
The new superbug Neisseria gonorrhoeae has retained resistance to antimicrobials previously recommended for first-line treatment and has now demonstrated its capacity to develop resistance to the extended-spectrum cephalosporin, ceftriaxone, the last remaining option for first-line empiric treatment of gonorrhea. An era of untreatable gonorrhea may be approaching, which represents an exceedingly serious public health problem. Herein, we review the evolution, origin and spread of antimicrobial resistance and resistance determinants (with a focus on extended-spectrum cephalosporins) in N. gonorrhoeae, detail the current situation regarding verified treatment failures with extended-spectrum cephalosporins and future treatment options, and highlight essential actions to meet the large public health challenge that arises with the possible emergence of untreatable gonorrhea. Essential actions include: implementing action/response plans globally and nationally; enhancing surveillance of gonococcal antimicrobial resistance, treatment failures and antimicrobial use/misuse; and improving prevention, early diagnosis and treatment of gonorrhea. Novel treatment strategies, antimicrobials (or other compounds) and, ideally, a vaccine must be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,698
Sexually Transmitted Diseases 7982 Treatment Guidelines
(1982) · American Pharmacy · doi:10.1016/s0160-3450(16)31823-2 · Cited by 1,573
Cohen, M. S., Hoffman, I. F., Royce, R. A., Kazembe, P., Dyer, J. R., Daly, C. C., Zimba, D., Vernazza, P. L., Maida, M., Fiscus, S. A., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02190-9 · Cited by 872
A universal vaccine for serogroup B meningococcus
Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Aricò, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603940103 · Cited by 727
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686
Self-citationUnemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., & Sednaoui, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05760-11 · Cited by 653
Self-citationGlobal prevalence and incidence estimates of selected curable STDs.
Gerbase, A. C., Rowley, J. T., Heymann, D., Berkley, S., & Piot, P. (1998) · PubMed · Cited by 524
Hagman, K. E., Spratt, B. G., Balthazar, J. T., Pan, W., Judd, R. C., & Shafer, W. M. (1995) · Microbiology · doi:10.1099/13500872-141-3-611 · Cited by 368
Camara, J., Serra, J., Ayats, J., Bastida, T., Carnicer-Pont, D., Andreu, A., & Ardanuy, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks162 · Cited by 339
Tapsall, J. W., Ndowa, F., Lewis, D. A., & Unemo, M. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.63 · Cited by 297
Self-citationThe Emerging Threat of Untreatable Gonococcal Infection
Bolan, G. A., Sparling, P. F., & Wasserheit, J. N. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1112456 · Cited by 279
UK national guideline for the management of gonorrhoea in adults, 2011
Bignell, C., FitzGerald, M., & (Guideline Development Group) (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011267 · Cited by 270
(2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.10.014 · Cited by 259
Ceftriaxone-Resistant Neisseria gonorrhoeae , Japan
Ohnishi, M., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Watanabe, H., & Kitawaki, J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.100397 · Cited by 236
Cathelicidin LL-37: A Multitask Antimicrobial Peptide
Bucki, R., Leszczyńska, K., Namiot, A., & Sokołowski, W. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0057-2 · Cited by 235
Unemo, M., & Shafer, W. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06215.x · Cited by 230
Self-citationUnemo, M., Fasth, O., Fredlund, H., Limnios, A., & Tapsall, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp098 · Cited by 226
Self-citationAmeyama, S., Onodera, S., Takahata, M., Minami, S., Maki, N., Endo, K., Goto, H., Suzuki, H., & Oishi, Y. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3744-3749.2002 · Cited by 222
Lindberg, R., Fredlund, H., Nicholas, R. A., & Unemo, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01604-06 · Cited by 212
Self-citationJerse, A. E., Sharma, N. D., Simms, A. N., Crow, E. T., Snyder, L. A., & Shafer, W. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5576-5582.2003 · Cited by 209
Ropp, P. A., Hu, M. Y., Olesky, M., & Nicholas, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.769-777.2002 · Cited by 206
Self-citationIto, M., Deguchi, T., Mizutani, K.-S., Yasuda, M., Yokoi, S., Ito, S.-I., Takahashi, Y., Ishihara, S., Kawamura, Y., & Ezaki, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.137-143.2005 · Cited by 205
Drugs of Choice for the Treatment of Uncomplicated Gonococcal Infections
Moran, J. S., & Levine, W. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_1.s47 · Cited by 202
Update on the Management of Gonorrhea in Adults in the United States
Newman, L. M., Moran, J. S., & Workowski, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/511422 · Cited by 197
Warner, D. M., Shafer, W. M., & Jerse, A. E. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06424.x · Cited by 192
Chisholm, S. A., Dave, J., & Ison, C. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00309-10 · Cited by 192
Unemo, M., Golparian, D., Syversen, G., Vestrheim, D. F., & Moi, H. (2010) · Eurosurveillance · doi:10.2807/ese.15.47.19721-en · Cited by 185
Self-citationVeal, W. L., Nicholas, R. A., & Shafer, W. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.20.5619-5624.2002 · Cited by 176
Self-citationCephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
Chisholm, S. A., Mouton, J. W., Lewis, D. A., Nichols, T., Ison, C. A., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq289 · Cited by 174
Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010
Ison, C. A., Hussey, J., Sankar, K. N., Evans, J., & Alexander, S. (2011) · Eurosurveillance · doi:10.2807/ese.16.14.19833-en · Cited by 172
Threat to Cefixime Treatment for Gonorrhea
Yokoi, S., Deguchi, T., Ozawa, T., Yasuda, M., Ito, S.-I., Kubota, Y., Tamaki, M., & Maeda, S.-I. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.060948 · Cited by 162
Zhao, S., Duncan, M., Tomberg, J., Davies, C., Unemo, M., & Nicholas, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00304-09 · Cited by 161
Self-citationThe use of cephalosporins for gonorrhea: the impending problem of resistance
Barry, P. M., & Klausner, J. D. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902731993 · Cited by 161
Unemo, M., Golparian, D., & Hestner, A. (2011) · Eurosurveillance · doi:10.2807/ese.16.06.19792-en · Cited by 154
Self-citationAre pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 151
Unemo, M., & Dillon, J. R. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-10 · Cited by 151
Self-citationBoslego, J. W., Tramont, E. C., Takafuji, E. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707303170504 · Cited by 149
Olesky, M., Hobbs, M. M., & Nicholas, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2811-2820.2002 · Cited by 148
Self-citationDecreased Azithromycin Susceptibility of Neisseria gonorrhoeae Due to mtrR Mutations
Zarantonelli, L., Borthagaray, G., Lee, E. H., & Shafer, W. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2468 · Cited by 146
Olesky, M., Zhao, S., Rosenberg, R. L., & Nicholas, R. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2300-2308.2006 · Cited by 144
Self-citationThe Gonococcus fights back: is this time a knock out?
Lewis, D. A. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2010.042648 · Cited by 143
Chisholm, S., Unemo, M., Quaye, N., Johansson, E. K., Cole, M. J., ISON, C. A., & van de Laar, M. J. W. (2013) · Eurosurveillance · doi:10.2807/ese.18.03.20358-en · Cited by 140
Self-citationUnemo, M., Golparian, D., Stary, A., & Eigentler, A. (2011) · Eurosurveillance · doi:10.2807/ese.16.43.19998-en · Cited by 139
Self-citationWarner, D. M., Folster, J. P., Shafer, W. M., & Jerse, A. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/522964 · Cited by 139
TAPSALL, J. W., Read, P. J., Carmody, C., Bourne, C., Ray, S., Limnios, A. E., Sloots, T. P., & Whiley, D. M. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.007641-0 · Cited by 138
Tomberg, J., Unemo, M., Davies, C., & Nicholas, R. A. (2010) · Biochemistry · doi:10.1021/bi101167x · Cited by 136
Self-citationThe pleuromutilin antibiotics: a new class for human use.
Novak, R., & Shlaes, D. M. (2010) · PubMed · Cited by 135
Hobbs, M. M., Sparling, P. F., Cohen, M. S., Shafer, W. M., Deal, C. D., & Jerse, A. E. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00123 · Cited by 130
Whiley, D. M., Limnios, E. A., Ray, S., Sloots, T. P., & TAPSALL, J. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00306-07 · Cited by 125
Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland
Palmer, H. M., Young, H.-K., Winter, A., & Dave, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn235 · Cited by 117
Katz, A. R., Komeya, A. Y., Soge, O. O., Kiaha, M., Lee, M. V. C., Wasserman, G. M., Maningas, E. V., Whelen, A. C., Kirkcaldy, R. D., Shapiro, S. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir929 · Cited by 114
Unemo, M., Golparian, D., Potočnik, M., & Jeverica, S. (2012) · Eurosurveillance · doi:10.2807/ese.17.25.20200-en · Cited by 109
Self-citationTanaka, M., Nakayama, H., Huruya, K., Konomi, I., Irie, S., Kanayama, A. K., Saika, T., & Kobayashi, I. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.021 · Cited by 109
Moran, J. S. (1995) · Sexually Transmitted Diseases · doi:10.1097/00007435-199501000-00007 · Cited by 106
Ito, M., Yasuda, M., Yokoi, S., Ito, S., Takahashi, Y., Ishihara, S., Maeda, S., & Deguchi, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3185-3187.2004 · Cited by 105
Deguchi, T., Yasuda, M., Yokoi, S., et al. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0204-8 · Cited by 104
Zhao, S., Tobiason, D. M., Hu, M. Y., Seifert, H. S., & Nicholas, R. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04752.x · Cited by 99
Self-citationVaccines for Gonorrhea: Can We Rise to the Challenge?
Zhu, W., Chen, C.-J., Thomas, C., Anderson, J. E., Jerse, A. E., & Sparling, P. F. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00124 · Cited by 97
Ohneck, E. A., Zalucki, Y. M., Johnson, P. J., Dhulipala, V., Golparian, D., Unemo, M., Jerse, A. E., & Shafer, W. M. (2011) · mBio · doi:10.1128/mbio.00187-11 · Cited by 92
Self-citationOsaka, K., Takahata, M., Takakura, T., Narukawa, K., Endo, K., Kiyota, H., & Onodera, S. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0610-7 · Cited by 90
Kunz, A. N., Begum, A. A., Wu, H., D'Ambrozio, J. A., Robinson, J. M., Shafer, W. M., Bash, M. C., & Jerse, A. E. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis277 · Cited by 88
Pandori, M., Barry, P. M., Wu, A., Ren, A., Whittington, W. L. H., Liska, S., & Klausner, J. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00406-09 · Cited by 87
Waites, K. B., Crabb, D. M., & Duffy, L. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00090-09 · Cited by 87
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy
Starnino, S., Stefanelli, P., & on behalf of the Neisseria gonorrhoeae Italian Study Group (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp118 · Cited by 86
Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates—United States, 2000-2010
(2011) · JAMA · doi:10.1001/jama.306.6.599 · Cited by 86
Golparian, D., Hellmark, B., Fredlund, H., & Unemo, M. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2010.045377 · Cited by 84
Self-citationProgrammes, W. W. A. S. G. A. S., & Tapsall, J. (2010) · Communicable Diseases Intelligence · doi:10.33321/cdi.2010.34.1 · Cited by 80
Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers
Borges, O., Lebre, F., Bento, D., Borchard, G., & Junginger, H. E. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-0011-3 · Cited by 77
Unemo, M., Golparian, D., Limnios, A. E., Whiley, D. M., Ohnishi, M., Lahra, M. M., & TAPSALL, J. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00326-12 · Cited by 77
Self-citationAkasaka, S., Muratani, T., Yamada, Y., et al. (2001) · Journal of Infection and Chemotherapy · doi:10.1007/s101560170034 · Cited by 75
Ndowa, F. J., Narasimhan, M., & Unemo, M. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050674 · Cited by 67
Self-citationTAPSALL, J. W. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.4.619 · Cited by 66
Ceftibuten Resistance and Treatment Failure ofNeisseria gonorrhoeaeInfection
Lo, J. Y. C., Ho, K., Leung, A. O. C., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-08 · Cited by 65
Martín, I., Sawatzky, P., Allen, V. G., Hoang, L., Lefebvre, B., Mina, N. V., Wong, T., & Gilmour, M. W. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182401b69 · Cited by 63
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Falagas, M. E., Karageorgopoulos, D. E., & Dimοpoulos, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048356 · Cited by 62
Liao, M., Gu, W.-M., Yang, Y., & Dillon, J.-A. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr021 · Cited by 61
Alexander, B. T., Marschall, J., Tibbetts, R. J., Neuner, E. A., Dunne, W. M., & Ritchie, D. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.05.002 · Cited by 60
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice
Burkhardt, O., Derendorf, H., & Welte, T. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.2.237 · Cited by 51
Gonococcal Resistance: Are Cephalosporins Next?
Kirkcaldy, R. D., Ballard, R. C., & Dowell, D. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0169-9 · Cited by 50
Starnino, S., Galarza, P. G., Carvallo, M. E. T., Benzaken, A. S., Ballesteros, A. M., Cruz, O. M. S., Hernández, A. L., Carbajal, J. L. P., Borthagaray, G., Payares, D., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182631c9f · Cited by 50
Ochiai, S., Ishiko, H., Yasuda, M., & Deguchi, T. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01800-07 · Cited by 48
TAPSALL, J. W. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2008.035337 · Cited by 47
Pharyngeal gonorrhoea – is dual therapy the way forward?
Sathia, L., Ellis, B., Phillip, S., Winston, A., & Smith, A. M. (2007) · International Journal of STD & AIDS · doi:10.1258/095646207781568556 · Cited by 44
Tanaka, M., Tunoe, H., Egashira, T., Naito, S., Nakayama, H., Kanayama, A. K., Saika, T., & Kobayashi, I. (2002) · Journal of Infection and Chemotherapy · doi:10.1007/s101560200011 · Cited by 43
Unemo, M., & collective on behalf of the European STI Guidelines Editorial Board (2012) · Eurosurveillance · doi:10.2807/ese.17.47.20323-en · Cited by 42
Self-citationHadad, R., Jacobsson, S., Pizza, M., Rappuoli, R., Fredlund, H., Olcén, P., & Unemo, M. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02903.x · Cited by 42
Self-citationTanaka, E., KIMOTO, T., Tsuyuguchi, K., et al. (2002) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0176-8 · Cited by 42
Lewis, D. A., & Lukehart, S. A. (2011) · Sexually Transmitted Infections · doi:10.1136/sti.2010.047712 · Cited by 40
Roblin, P. M., Kohlhoff, S. A., Parker, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01343-09 · Cited by 40
Deshpande, L. M., Gales, A. C., & Jones, R. N. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00355-7 · Cited by 39
Ochiai, S., Sekiguchi, S., Hayashi, A., Shimadzu, M., Ishiko, H., Matsushima‐Nishiwaki, R., Kozawa, O., Yasuda, M., & Deguchi, T. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm166 · Cited by 39
Trends in Antimicrobial Resistance in Neisseria gonorrhoeae Isolated in Canada: 2000–2009
Martín, I., Jayaraman, G., Wong, T., Liu, G., & Gilmour, M. W. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822c664f · Cited by 38
Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae
Johnson, S. R., Sandul, A. L., Parekh, M., Wang, S. A., Knapp, J. S., & Trees, D. L. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00039-6 · Cited by 38
Goire, N., Ohnishi, M., Limnios, A. E., Lahra, M. M., Lambert, S. B., Nimmo, G. R., Nissen, M. D., Sloots, T. P., & Whiley, D. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr549 · Cited by 32
Shafer, W. M., & Folster, J. P. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2297-2299.2006 · Cited by 30
Tanaka, M., Koga, Y., Nakayama, H., et al. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31821d0f98 · Cited by 26
The use of cephalosporins for gonorrhea: an update on the rising problem of resistance
Stoltey, J. E., & Barry, P. M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.690396 · Cited by 20
Johnson, P. J., Stringer, V. A., & Shafer, W. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00010-11 · Cited by 19
Buono, S. A., Wu, A., Hess, D. C., Carlson, J. S., Rauch, L. M., Philip, S., Barry, P. M., Bernstein, K. T., Klausner, J. D., & Pandori, M. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0229 · Cited by 18
Morris, S., Knapp, J. S., Moore, D. F., et al. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.030163 · Cited by 18
Dillon, J. R. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318232459b · Cited by 16
Takahashi, S., Kurimura, Y., Hashimoto, J., et al. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0450-3 · Cited by 15
Saika, T., Nishiyama, T., Kanayama, A. K., Kobayashi, I., Nakayama, H., Tanaka, M., & Naito, S. (2001) · Journal of Infection and Chemotherapy · doi:10.1007/s101560100031 · Cited by 15
Cited by
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
Unemo, M., & Shafer, W. M. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-14 · Cited by 1,151
Self-citationSexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Self-citationUpdate on the antibiotic resistance crisis
Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.006 · Cited by 695
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults
Bignell, C., Unemo, M., The European STI Guidelines Editorial Board, Radcliffe, K., Jensen, J. S., Babayan, K., Barton, S., Cusini, M., Gomberg, M., Janier, M., et al. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472837 · Cited by 483
Self-citationAntimicrobial resistance—a threat to the world’s sustainable development
Jasovský, D., Littmann, J., Zorzet, A., & Cars, O. (2016) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2016.1195900 · Cited by 442
Metadata
- Authors
- Unemo, M., & Nicholas, R. A.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2012-12
- Volume
- 7
- Issue
- 12
- Pages
- 1401-1422
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2111450162
- Cited by
- 421
- References
- 104
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.